BOSTON--(BUSINESS WIRE)--GE Healthcare introduced today a new portfolio of ready-to-use systems and devices designed for biopharmaceutical production. The ReadyToProcessTM portfolio is a range of products designed to meet the biopharmaceutical industry’s need for increased speed, simplicity and safety for all areas of bioprocessing - from cell culture and fermentation to final purification.
